Group 1 - KBR, Inc. is under investigation by Bragar Eagel & Squire, P.C. for potential violations of federal securities laws and unlawful business practices [1] - On June 20, 2025, KBR announced that its joint venture, HomeSafe Alliance, had its role in the Global Household Goods Contract terminated by U.S. Transportation Command, leading to a significant stock price drop of $3.85 per share, or 7.29%, closing at $48.93 [2] - The law firm is reaching out to KBR stockholders who may have suffered losses and is encouraging them to participate in the investigation [3] Group 2 - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents investors in complex litigation across state and federal courts [4]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Hims To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) ...

Core Viewpoint - KBR, Inc. experienced a significant decline in share price following the cancellation of a major contract with the U.S. Department of Defense, raising concerns about potential misrepresentation of the contract's status to investors [1][4][5]. Group 1: Contract Details - KBR's joint venture, HomeSafe Alliance LLC, was awarded a contract valued at $20 billion with a potential term of 9 years to manage household goods for the U.S. Armed Services and Department of Defense [3]. - The contract was terminated by TRANSCOM due to HomeSafe's failure to meet obligations, which included issues like delays and damaged items [4][5]. Group 2: Investor Reactions and Investigations - Following the contract cancellation announcement, KBR's share price fell by $3.85, or 7.3%, on June 20, 2025 [5]. - Hagens Berman, a national shareholders rights firm, has initiated an investigation into KBR for possible violations of securities laws related to prior positive statements about the contract [2][5]. Group 3: Company Assurances - As recently as May 6, 2025, KBR management expressed confidence in the contract's status, claiming a strong relationship with TRANSCOM [4][7]. - However, just weeks later, it was revealed that HomeSafe had been struggling with various challenges related to the contract, contradicting KBR's earlier assurances [5].

Core Viewpoint - Hims & Hers Health, Inc. experienced a significant share price drop of over 30% following the termination of its collaboration with Novo Nordisk due to concerns regarding sales practices and marketing of the weight loss drug Wegovy® [1][4]. Company Summary - Hims & Hers Health, Inc. had previously partnered with Novo Nordisk to provide access to Wegovy®, which is FDA-approved for obesity treatment, through its platform [3]. - The partnership was short-lived, as Novo Nordisk cited "illegal mass compounding and deceptive marketing" as reasons for the termination [4]. - Hims & Hers had previously assured investors of its regulatory compliance, claiming it was not bypassing the regulatory process [2]. Investigation Summary - Hagens Berman, a national shareholders rights firm, has initiated an investigation into potential violations of securities laws by Hims & Hers, urging affected investors to report their losses [2]. - The investigation will focus on whether Hims & Hers misled investors regarding the marketing of potentially unsafe versions of Wegovy® [4].

Core Viewpoint - The share price of CTO Realty Growth, Inc. significantly declined following allegations from Wolfpack Research regarding misleading statements about dividend sustainability and questionable financial practices [1]. Group 1: Allegations and Investigations - Hagens Berman, a national shareholders rights firm, has initiated an investigation into CTO Realty Growth, Inc. to determine if the company violated securities laws and is urging affected investors to report their losses [2]. - The investigation focuses on CTO's claims of adhering to accounting rules and the use of non-GAAP accounting metrics, particularly concerning the quality of its real estate portfolio and reported asset values [3][5]. Group 2: Financial Distress and Management Practices - Wolfpack Research's report indicates that CTO's management has misrepresented the quality of its properties, revealing that some are in severe financial distress and that the company relies on dilution to cover a $38 million dividend shortfall [4]. - The report criticizes CTO's definition of Adjusted Funds From Operation (AFFO), claiming it excludes recurring capital expenditures, which is not consistent with industry peers, and suggests that management's compensation is inflated based on this metric [5]. Group 3: Whistleblower Information - Whistleblowers with non-public information about CTO Realty Growth are encouraged to assist in the investigation, with potential rewards under the SEC Whistleblower program for original information leading to successful recovery [6].

SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- On June 23, 2025 investors in Hims & Hers Health, Inc. (NYSE: HIMS) saw the price of their shares crash over 30% after Novo Nordisk announced that it terminated its collaboration with the telehealth company due to concerns about Hims & Hers’ sales and “deceptive” marketing of the weight loss drug Wegovy®. This news has prompted national shareholders rights firm Hagens Berman to open an investigation into possible violations of the securities laws. The firm ur ...

NEW YORK, June 23, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA). Shareholders who purchased shares of IOVA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/iovance-biotherapeutics-inc-loss-submission-form/? id=153664&from=4 DEAD ...

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Compass Diversified Holdings (“Compass” or the “Company”) (NYSE: CODI) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws. CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION Compass own ...

Core Viewpoint - The Gross Law Firm is notifying shareholders of Strategy Incorporated (NASDAQ: MSTR) about a class action lawsuit related to misleading statements regarding the company's bitcoin investment strategy and treasury operations [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from April 30, 2024, to April 4, 2025 [2]. - Allegations include that the company overstated the anticipated profitability of its bitcoin-focused strategy and understated the risks associated with bitcoin's volatility [2]. - Shareholders are encouraged to register for the class action by July 15, 2025, to potentially become lead plaintiffs [3]. Group 2: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit, fraud, and illegal business practices [4]. - The firm is committed to ensuring companies engage in responsible business practices and good corporate citizenship [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Strategy Incorporated (NASDAQ: MSTR) regarding a class action lawsuit due to alleged misleading statements related to the company's bitcoin investment strategy and treasury operations [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from April 30, 2024, to April 4, 2025 [3]. - Allegations include that the company overstated the anticipated profitability of its bitcoin-focused investment strategy and treasury operations, understated the risks associated with bitcoin's volatility, and failed to disclose potential losses from its digital assets following the adoption of ASU 2023-08 [3]. Deadlines and Next Steps for Shareholders - Shareholders are encouraged to register for the class action by the deadline of July 15, 2025 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [4]. Law Firm's Mission and Commitment - The Gross Law Firm aims to protect the rights of investors who have suffered due to deceit, fraud, and illegal business practices, ensuring companies adhere to responsible business practices [5].